A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Big deal: Oxford PV begins capturing series D Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m. Respirion inhales $14.2m Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.